Is obesity a major cause of chronic kidney disease?

Excess weight gain is a major risk factor for essential hypertension and for end-stage renal disease (ESRD). Obesity raises blood pressure by increasing renal tubular sodium reabsorption, impairing pressure natriuresis, and causing volume expansion because of activation of the sympathetic nervous system and renin-angiotensin system and by physical compression of the kidneys, especially when visceral obesity is present. Obesity also causes renal vasodilation and glomerular hyperfiltration that initially serve as compensatory mechanisms to maintain sodium balance in the face of increased tubular reabsorption. In the long-term, however, these changes, along with the increased systemic arterial pressure, create a hemodynamic burden on the kidneys that causes glomerular injury. With prolonged obesity, there is increasing urinary protein excretion and gradual loss of nephron function that worsens with time and exacerbates hypertension. With the worsening of metabolic disturbances and the development of type II diabetes in some obese patients, kidney disease progresses much more rapidly. Weight reduction is an essential first step in the management of obesity, hypertension, and kidney disease. Special considerations for the obese patient, in addition to adequately controlling the blood pressure, include correction of the metabolic abnormalities and protection of the kidneys from further injury.

[1]  H. Tran Obesity-related glomerulopathy. , 2004, The Journal of clinical endocrinology and metabolism.

[2]  Christopher J. Lyon,et al.  Minireview: adiposity, inflammation, and atherogenesis. , 2003, Endocrinology.

[3]  T. Weinstein,et al.  The effects of weight loss on renal function in patients with severe obesity. , 2003, Journal of the American Society of Nephrology : JASN.

[4]  M. Esler,et al.  Interactions Between Leptin and the Human Sympathetic Nervous System , 2003, Hypertension.

[5]  S. Oparil Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): Practical Implications , 2003, Hypertension.

[6]  J. Kuo,et al.  Hypothalamic Melanocortin Receptors and Chronic Regulation of Arterial Pressure and Renal Function , 2003, Hypertension.

[7]  John E. Hall,et al.  Obesity-associated hypertension and kidney disease , 2003, Current opinion in nephrology and hypertension.

[8]  John E Hall,et al.  The kidney, hypertension, and obesity. , 2003, Hypertension.

[9]  E. Benjamin,et al.  Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[10]  E. Morales,et al.  Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  M. Picken,et al.  Renoprotection by ACE Inhibition or Aldosterone Blockade Is Blood Pressure–Dependent , 2003, Hypertension.

[12]  T. Kurtz False Claims of Blood Pressure–Independent Protection by Blockade of the Renin Angiotensin Aldosterone System? , 2003, Hypertension.

[13]  J. Sowers,et al.  Treatment of cardiovascular and renal risk factors in the diabetic hypertensive. , 2002, Hypertension.

[14]  S. Beske,et al.  Sympathetic Neural Activation in Visceral Obesity , 2002, Circulation.

[15]  S. Haffner,et al.  Hypertension, Insulin, and Proinsulin in Participants With Impaired Glucose Tolerance , 2002, Hypertension.

[16]  Megan Jehn,et al.  Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT). , 2002, Hypertension.

[17]  Arya M. Sharma,et al.  Angiotensin blockade prevents type 2 diabetes by formation of fat cells. , 2002, Hypertension.

[18]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.

[19]  S. Daniels,et al.  Obesity hypertension in children: a problem of epidemic proportions. , 2002, Hypertension.

[20]  Daniel W. Jones,et al.  Mechanisms of obesity-associated cardiovascular and renal disease. , 2002, The American journal of the medical sciences.

[21]  D. A. Maddox,et al.  Prevention of obesity-linked renal disease: age-dependent effects of dietary food restriction. , 2002, Kidney international.

[22]  M. Praga Obesity--a neglected culprit in renal disease. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  E. Jéquier Leptin Signaling, Adiposity, and Energy Balance , 2002, Annals of the New York Academy of Sciences.

[24]  A. Rocchini Obesity hypertension*1 , 2002 .

[25]  John E. Hall,et al.  Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity , 2002, Hypertension.

[26]  H. Pollack,et al.  Epidemic increase in childhood overweight, 1986-1998. , 2001, JAMA.

[27]  M. Esler,et al.  Sympathetic nervous system and insulin resistance: from obesity to diabetes. , 2001, American journal of hypertension.

[28]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[29]  N. Abate,et al.  Overweight and Sympathetic Overactivity in Black Americans , 2001, Hypertension.

[30]  A. Ribeiro,et al.  Treatment of obesity hypertension and diabetes syndrome. , 2001, Hypertension.

[31]  Daniel W. Jones,et al.  Antihypertensive effect of α- and β-adrenergic blockade in obese and lean hypertensive subjects , 2001 .

[32]  S. Bigler,et al.  Functional and structural changes in the kidney in the early stages of obesity. , 2001, Journal of the American Society of Nephrology : JASN.

[33]  J. Hall,et al.  Obesity hypertension: role of leptin and sympathetic nervous system. , 2001, American journal of hypertension.

[34]  U. Alon,et al.  Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. , 2001, The Journal of pediatrics.

[35]  T. Pischon,et al.  Choice of drug treatment for obesity-related hypertension: where is the evidence? , 2001, Journal of hypertension.

[36]  F. Berthoux,et al.  Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  D. Heudes,et al.  Inflammation is probably not a prerequisite for renal interstitial fibrosis in normoglycemic obese rats. , 2001, American journal of physiology. Renal physiology.

[38]  V. D’Agati,et al.  Obesity-related glomerulopathy: an emerging epidemic. , 2001, Kidney international.

[39]  A. Mark,et al.  Leptin Acts in the Central Nervous System to Produce Dose-Dependent Changes in Arterial Pressure , 2001, Hypertension.

[40]  J. Stern,et al.  Calorie restriction in obesity: prevention of kidney disease in rodents. , 2001, Journal of NutriLife.

[41]  A. Dobrian,et al.  Oxidative Stress in a Rat Model of Obesity-Induced Hypertension , 2001, Hypertension.

[42]  O. B. Jones,et al.  Inhibition of NO Synthesis Enhances Chronic Cardiovascular and Renal Actions of Leptin , 2001, HYPERTENSION.

[43]  J. Rodicio,et al.  Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. , 2000, Kidney international.

[44]  E. Ravussin,et al.  Ethnic Differences in Insulinemia and Sympathetic Tone as Links Between Obesity and Blood Pressure , 2000, Hypertension.

[45]  G. Mancia,et al.  Adrenergic and Reflex Abnormalities in Obesity-Related Hypertension , 2000, Hypertension.

[46]  J. Karlberg,et al.  Blood pressure is associated with body mass index in both normal and obese children. , 2000, Hypertension.

[47]  T. Dwyer,et al.  Distribution of renal medullary hyaluronan in lean and obese rabbits. , 2000, Kidney international.

[48]  T. Weinstein,et al.  Glomerular hemodynamics in severe obesity. , 2000, American journal of physiology. Renal physiology.

[49]  W. Keane,et al.  The role of lipids in renal disease: future challenges. , 2000, Kidney international. Supplement.

[50]  P. Whelton,et al.  Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. , 2000, Hypertension.

[51]  A. Mark,et al.  Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. , 1999, Journal of hypertension.

[52]  J Licinio,et al.  Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defe , 1999, The Journal of clinical endocrinology and metabolism.

[53]  J. C. Romero,et al.  State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension. , 1999, Hypertension.

[54]  C. Rotimi,et al.  The puzzle of hypertension in African-Americans. , 1999, Scientific American.

[55]  B. Falkner,et al.  Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group. , 1997, Hypertension.

[56]  H. Sugerman,et al.  Intra‐abdominal pressure, sagittal abdominal diameter and obesity comorbidity , 1997, Journal of internal medicine.

[57]  J. Hall,et al.  Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. , 1996, Hypertension.

[58]  A. Mimran,et al.  Combined renal effects of overweight and hypertension. , 1995, Hypertension.

[59]  L. Ruilope,et al.  Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. , 1995, Nephron.

[60]  J. Granger,et al.  Renal denervation attenuates the sodium retention and hypertension associated with obesity. , 1995, Hypertension.

[61]  H. Mizelle,et al.  Renal sinus lipomatosis and body composition in hypertensive, obese rabbits. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[62]  Daniel W. Jones,et al.  Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey , 1994, Journal of hypertension.

[63]  A. Kissebah,et al.  Regional adiposity and morbidity. , 1994, Physiological reviews.

[64]  J. Hall,et al.  Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. , 1994, Hypertension.

[65]  J. Ménard,et al.  Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension. , 1994, American journal of hypertension.

[66]  P. Iozzo,et al.  Absence of clinically overt atherosclerotic vascular disease and adverse changes in cardiovascular risk factors in 70 patients with insulinoma , 1993, Journal of endocrinological investigation.

[67]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[68]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .

[69]  J. Hall,et al.  Obesity-induced hypertension. Renal function and systemic hemodynamics. , 1993, Hypertension.

[70]  E. Reisin,et al.  Low calorie unrestricted protein diet attenuates renal injury in hypertensive rats. , 1993, Hypertension.

[71]  J. Hall,et al.  Hyperinsulinemia: a link between obesity and hypertension? , 1993, Kidney international.

[72]  L. Landsberg,et al.  Obesity, metabolism, and the sympathetic nervous system. , 1989, American journal of hypertension.

[73]  W. Kannel,et al.  Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. , 1987, Preventive medicine.

[74]  S. Textor,et al.  Blood Pressure Regulation in Pheochromocytoma , 1982, Hypertension.

[75]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy , 2002 .

[76]  A. Mark,et al.  Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. , 1999, Hypertension.

[77]  W. Border,et al.  Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. , 1998, Hypertension.

[78]  J. Hall,et al.  Chronic leptin infusion increases arterial pressure. , 1998, Hypertension.

[79]  D. Wesson,et al.  Massive obesity and nephrotic proteinuria with a normal renal biopsy. , 1985, Nephron.